← Leaderboards
David M Aronoff
University Of Michigan At Ann Arbor
$10,002,603
Attributed
$12,949,212
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,949,212 · 12
By mechanism
R01$6,511,156 · 3
U19$1,842,006 · 1
R21$1,777,326 · 4
U01$1,551,088 · 1
K08$661,500 · 1
R56$596,136 · 1
Top collaborators
- Jennifer A Gaddy5 shared
- Thomas A Hooven2 shared
- Anup Prasant Aron Challa1 shared
- Erik R Dubberke1 shared
- Shannon D. Manning1 shared
- Sarah Kelly Mcgill1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Leslie J Crofford$13,141,649
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionBacteriaPathogenTissuesPathogenesisMacrophageIn VivoPregnancyHost DefenseVaginaMembraneLeadPreventionMouse ModelPreventBaseUterusCessation Of LifeCellsResponseMothersAntibioticsInvadedAffect
Grant awards (36)
Bacterial CRISPR interference to define macrophage responses to group B Streptococcus proteins$198,413
R21 · FY2024 · AI
Bacterial CRISPR interference to define macrophage responses to group B Streptococcus proteins$252,913
R21 · FY2023 · AI
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections$374,325
R01 · FY2021 · HD
The Role of macrophages in chorioamnionitis and group B streptococcal infections$266,794
R01 · FY2021 · AI · contact PI
Clinical trial emulation to assess drug safety in pregnant patients$259,500
R21 · FY2021 · HD · contact PI
The Role of macrophages in chorioamnionitis and group B streptococcal infections$205,788
R01 · FY2021 · AI · contact PI
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections$500,207
R01 · FY2020 · HD
The Role of macrophages in chorioamnionitis and group B streptococcal infections$472,582
R01 · FY2020 · AI · contact PI
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections$555,769
R01 · FY2019 · HD
The Role of macrophages in chorioamnionitis and group B streptococcal infections$472,582
R01 · FY2019 · AI · contact PI
Repurposing misoprostol to prevent recurrence of Clostridium difficile infection$1,551,088
U01 · FY2018 · TR · contact PI
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections$543,451
R01 · FY2018 · HD
The Role of macrophages in chorioamnionitis and group B streptococcal infections$478,701
R01 · FY2018 · AI · contact PI
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infections$544,387
R01 · FY2017 · HD
The Role of macrophages in chorioamnionitis and group B streptococcal infections$495,463
R01 · FY2017 · AI · contact PI
Repurposing misoprostol for Clostridium difficile colitis as identified by PheWAS$276,500
R21 · FY2017 · TR · contact PI
Prostaglandins as protective mediators in Clostridium difficile infection$197,500
R21 · FY2017 · AI · contact PI
Repurposing misoprostol for Clostridium difficile colitis as identified by PheWAS$355,500
R21 · FY2016 · TR · contact PI
Prostaglandins as protective mediators in Clostridium difficile infection$237,000
R21 · FY2016 · AI · contact PI
ANAEROBE 2016: The 13th Biennial Congress of the Anaerobe Society of the Americas (ASA)$10,000
R13 · FY2016 · AI · contact PI
Epidemiology and Genomics of Clostridium difficile$371,916
U19 · FY2014 · AI · contact PI
Epidemiology and Genomics of Clostridium difficile$311,808
U19 · FY2013 · AI · contact PI
Mechanisms of group B streptococcal interactions with extraplacental membranes$596,136
R56 · FY2012 · AI · contact PI
Epidemiology and Genomics of Clostridium difficile$374,663
U19 · FY2012 · AI · contact PI
Role of misoprostol in Clostridium sordellii endometritis in a rodent model$311,519
R01 · FY2012 · HD · contact PI
Epidemiology and Genomics of Clostridium difficile$392,118
U19 · FY2011 · AI · contact PI
Role of misoprostol in Clostridium sordellii endometritis after medical abortion$311,519
R01 · FY2011 · HD · contact PI
Epidemiology and Genomics of Clostridium difficile$391,501
U19 · FY2010 · AI · contact PI
Role of misoprostol in Clostridium sordellii endometritis after medical abortion$324,499
R01 · FY2010 · HD · contact PI
Role of misoprostol in Clostridium sordellii endometritis after medical abortion$326,785
R01 · FY2009 · HD · contact PI
Modulation of Lung Innate Immunity Prostaglandin E2$132,300
K08 · FY2009 · HL · contact PI
Role of misoprostol in Clostridium sordellii endometritis after medical abortion$326,785
R01 · FY2008 · HD · contact PI
Modulation of Lung Innate Immunity by Prostaglandin E2$132,300
K08 · FY2008 · HL · contact PI
Modulation of Lung Innate Immunity by Prostaglandin E2$132,300
K08 · FY2007 · HL · contact PI
Modulation of Lung Innate Immunity Prostaglandin E2$132,300
K08 · FY2006 · HL · contact PI
Modulation of Lung Innate Immunity by Prostaglandin E2$132,300
K08 · FY2005 · HL